Penghui Zhou
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
GITR activation potentiates anti-tumor immunity of tumor-infiltrating lymphocytes expanded from glioblastoma by rescuing exhaustion.
Journal: Oncogene
Published: June 18, 2025
PDZ domains of PATJ facilitate immunological synapse formation to promote T cell activation.
Journal: Journal for immunotherapy of cancer
Published: April 16, 2025
Tuning the sensitivity of mechanosensory receptors through histidine scanning.
Journal: Cell
Published: April 04, 2025
Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ-IRF1-SREBF2 Axis.
Journal: Cancer immunology research
Published: February 24, 2025
CBX2 suppresses interferon signaling to diminish tumor immunogenicity via a noncanonical corepressor complex.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 30, 2025
Publisher Correction: Cytoplasmic FBXO38 mediates PD-1 degradation.
Journal: EMBO reports
Published: November 02, 2024
Tryptophan Metabolite Indole-3-Aldehyde Induces AhR and c-MYC Degradation to Promote Tumor Immunogenicity.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 12, 2024
Correction: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 26, 2024
Membranolytic peptide programs immunogenic cell death for cancer therapy.
Journal: Nature
Published: March 19, 2024
Activated STING-containing R-EVs from iPSC-derived MSCs promote antitumor immunity.
Journal: Cancer letters
Published: March 12, 2024
Last Updated: 09/26/2026